Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma

British Journal of Cancer

Volumn 79, Issue 1, 1999, Pages 164-167

  Mihara, M ^a,b   Nimura, Y ^a,b   Ichimiya, S ^a   Sakiyama, S ^a   Kajikawa, S ^b   Adachi, W ^b   Amano, J ^b   Nakagawara, A ^a  

^a CHIBA CANCER CENTER   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1p36.3; Hepatocellular carcinoma; mRNA expression; Mutation; p53; p73

Indexed keywords

CORE PROTEIN;

ARTICLE; CHROMOSOME 1P; CLINICAL ARTICLE; GENE MUTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; NEUROBLASTOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

EID: 0032889050     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690027     Document Type: Article

References (31)

1. Bressac B, Kew M, Wands J and Ozturk M (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431
2. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A and Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852-8856
3. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloreform extraction. Anal Biochem 162: 156-159
4. Coursaget P, Depril N, Chabaud M, Nandi R, Mayelo V, LeCann P and Yvonnet B (1993) High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 67: 1395-1397
5. Ding SF, Habib NA, Dooley J, Wood C, Bewies L and Delhanty DA (1991) Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 64: 1083-1087
6. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K and Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89-93
7. Henkler F, Waseem N, Golding MHC, Alison MR and Koshy R (1995) Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Res 55: 6084-6091
8. Honda K, Sbisa E, Tullo A, Papeo PA, Saccone C, Poole S, Pignatelli M, Mistry RR, Ding S, Isla A, Davis A and Habib NA (1998) p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumor ablation. Br J Cancer 77: 776-782
9. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 350: 427-428
10. Jost CA, Marin MC and Kaelin Jr WG (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194
11. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
12. Kazachkov Y, Khaoustov V, Yoffe B, Solomon H, Klintmalm GBG and Tabor E (1996) p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis 17: 2207-2212
13. Knudson Jr AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
14. Kress S, Jahn UR, Buchmann A, Bannasch P and Schwarz M (1992) p53 mutation in human hepatocellular carcinomas from Germany. Cancer Res 52: 3220-3223
15. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Knematsu T and Nakamura Y (1995) Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chrom Cancer 13: 163-167
16. Levine AJ, Momand J and Findlay CA (1991) The p53 tumor suppressor gene. Nature 351: 453-456
17. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY and Santella RM (1997) p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57: 3471-3477
18. Möröy T, Marchio A, Etiemble J, Trepo C, Tiollais P and Buendia MA (1986) Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 324: 276-279
19. Murakami Y, Hayashi K and Sekiya T (1991) Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res 51: 3356-3361
20. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A (1997) Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927-2933
21. Nimura Y, Mihara M, Ichimiya S, Sakiyama S, Seki N, Ohira M, Nomura N, Fujimori M, Adachi W, Amano J, He M, Ping Y-M and Nakagawara A (1998) p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer (in press)
22. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H and Ishizaki K (1993) Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 53: 368-372
23. Piao Z, Kim H, Jeon BK, Lee WJ and Park C (1997) Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 80: 865-872
24. Ray RB, Steele R, Meyer K and Ray R (1997) Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272: 10983-10986
25. Simon D, Knowles BB and Weith A (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6: 765-770
26. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K and Maeda S (1994) p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54: 231-235
27. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T and Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791-6794
28. Vesey DA, Hayward NK and Cooksley WGE (1994) p53 gene in hepatocellular carcinoma from Australia. Cancer Detect Prev 18: 123-130
29. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319: 525-532
30. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JHJ and Harris CC (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 55: 6012-6016
31. Yeh SH, Chen PJ, Chen HL, Lai MY, Wang CC and Chen DS (1994) Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinoma. Cancer Res 54: 4188-4192